Polycythemia Vera Market Size To Hit US$ 6,338.8 Million By 2033
According to IMARC Group’s latest report, titled “ Polycythemia Vera Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033 ”, The 7 major polycythemia vera markets reached a value of US$ 1,500 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 6,338.8 Million by 2033, exhibiting a growth rate (CAGR) of 14% during 2023-2033.This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form. Industry Definition and Application: Polycythemia vera is a rare, chronic blood disorder marked by excessive production of white blood cells (WBCs), red blood cells (RBCs), and platelets in the bone marrow. This leads to increased blood volume and thickness, potentially causing complications like heart attacks and strokes. Common symptoms include itchiness, abdominal pain, nosebleeds, a swollen big toe, shortness of breath, and n...